Financials
- Market Capitalization 2.08 B
- Employee 398
- Founded 1989
- CEO Nick Colangelo
- Website www.vcel.com
- Headquarter Michigan, United States
- FIGI BBG000BDCM24
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
112.53
市销率
6.8
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1905 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 8.36 USD | -2.22% | +2.58% | +2.33% | +27.05% | 2.14 B USD | ||
| 1918 | NVAX Novavax, Inc. - Common Stock | 12.66 USD | -0.71% | +2.43% | +34.39% | +46.19% | 2.09 B USD | ||
| 1923 | VRDN Viridian Therapeutics, Inc. - Common Stock | 18.30 USD | -1.93% | -4.34% | -14.76% | -18.49% | 2.07 B USD | ||
| 1948 | PHVS Pharvaris N.V. - Ordinary Shares | 30.89 USD | -0.68% | +1.28% | -19.24% | +41.70% | 2.01 B USD |